Which statement best describes dosing considerations for drugs in hepatic impairment?

• A. Metabolism is increased; dosing intervals can be lengthened
• B. No change in metabolism; monitor kidney function
• C. Metabolism is reduced; increased risk of accumulation; adjust dose or dosing interval; monitor liver function tests
• D. Only intravenous drugs are affected

Answer: (C)